Divi's Laboratories Ltd

Common Name

Divi's Laboratories

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

10,542

Ticker

DIVISLAB

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

www.divislabs.com

Description

Divi's Laboratories Ltd. is a prominent pharmaceutical company based in India, renowned for its research-driven approach in the development and manufacturing of active pharmaceutical ingredients (APIs... Show more

Financial Statements of Divi's Laboratories

Below are the financial statements of Divi's Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of INR	2025	2024
Non-current assets	—	—
Property, plant and equipment	54.37^a	47.33^a
Right of use assets	0.01^a	0.02^a
Capital work-in-progress	10.22^a	7.78^a
Intangible assets	0.04^a	0.04^a
Financial assets	—	—
Investments	0.65^a	0.82^a
Other financial assets	0.62^a	0.56^a
Income tax assets (net)	0.01^a	0.01^a
Deferred tax asset	0.11^a	0.1^a
Other non-current assets	2.48^a	1.29^a
Total non-current assets	68.51^a	57.95^a
Current assets	—	—
Inventories	32.36^a	31.84^a
Financial assets	—	—
Trade receivables	27.31^a	21.56^a
Cash and cash equivalents	4.15^a	3.63^a
Bank balances other than above	33^a	36.17^a
Other financial assets	0.16^a	0.07^a
Income tax assets (net)	0.13^a	0.28^a
Other current assets	3.7^a	3.2^a
Total current assets	100.81^a	96.75^a
Total assets	169.32^a	154.7^a
Equity	—	—
Equity share capital	0.53^a	0.53^a
Other equity	149.16^a	135.18^a
Total equity	149.69^a	135.71^a
Lease liabilities	0.02^a	0.02^a
Non-current liabilities	—	—
Provisions	0^a	0.37^a
Deferred tax liabilities (net)	5.09^a	5.82^a
Total non-current liabilities	5.11^a	6.21^a
Financial liabilities	—	—
Borrowings	0.02^a	0^a
Lease liabilities	0^a	0.01^a
Trade payables	—	—
Total outstanding dues of micro and small enterprises	0.37^a	0.35^a
Total outstanding dues other than above	8.73^a	7.89^a
Other financial liabilities	1.34^a	1^a
Current liabilities	—	—
Current tax liabilities	0^a	0.43^a
Other current liabilities	3.52^a	3.03^a
Provisions	0.54^a	0.07^a
Total current liabilities	14.52^a	12.78^a
Total liabilities	19.63^a	18.99^a
Total equity and liabilities	169.32^a	154.7^a

Verified Sources Behind Divi's Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Divi's Laboratories’s data sources below and access millions more through our Disclosure Search.

a. Divi's Laboratories's Annual Report 2025

Trace every data point back to Divi's Laboratories’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Divi's Laboratories Ltd

Financial Statements of Divi's Laboratories

Verified Sources Behind Divi's Laboratories’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Alkem Laboratories Ltd

Torrent Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd

Cipla Ltd

Lupin Ltd

Zydus Lifesciences Ltd